Latest Information Update: 27 Nov 2007
At a glance
- Originator Immtech Pharmaceuticals
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cryptosporidiosis; Giardiasis
Most Recent Events
- 01 Oct 1999 Preclinical development for Cryptosporidiosis in USA (Unknown route)
- 01 Oct 1999 Preclinical development for Giardiasis in USA (Unknown route)